Legal Representation
Attorney
Andrew Baum
USPTO Deadlines
Application History
42 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 8, 2016 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Jan 8, 2016 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
Oct 19, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 28, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
May 28, 2015 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
May 28, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
May 5, 2015 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 5, 2015 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 28, 2015 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Oct 28, 2014 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
Oct 28, 2014 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
Oct 28, 2014 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
Oct 2, 2014 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
Aug 20, 2014 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Apr 1, 2014 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Apr 1, 2014 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Apr 1, 2014 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Mar 20, 2014 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Mar 20, 2014 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 14, 2014 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
Oct 2, 2013 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
Oct 2, 2013 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
Oct 2, 2013 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
Sep 19, 2013 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
Mar 15, 2013 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
Mar 15, 2013 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
Mar 15, 2013 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
Mar 7, 2013 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Mar 7, 2013 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 7, 2013 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Mar 7, 2013 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Jan 31, 2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jan 31, 2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 24, 2013 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jan 22, 2013 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jan 22, 2013 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jul 23, 2012 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 23, 2012 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jul 23, 2012 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 10, 2012 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 4, 2012 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Apr 2, 2012 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific, technical and research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of pharmaceutical side effects, genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; design and development of databases featuring biomarker data; providing an online searchable database for clinical and scientific research in the field of medical, diagnostic and treatment research; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Providing an online database featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options; medical consulting services with respect to the treatment and diagnosis of individuals in the fields of clinical pharmacology and the analysis of dose effect relationships for treatment purposes; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; medical consulting services in the fields of patient treatment and treatment protocols; consulting services in the field of pharmaceuticals and genetics, namely, conducting drug safety and dosage assessment and in drug compatibility studies in the field of cancer treatment therapy for others relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Translation
The English translation of "CLINICO" in the mark is CLINICAL.
Classification
International Classes
035
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"INFORMATICS"